Sterling Capital Management’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.7K | Buy |
2,396
+853
| +55% | +$4.53K | ﹤0.01% | 1983 |
|
|
2025
Q1 | $13.7K | Sell |
1,543
-1,321
| -46% | -$11.7K | ﹤0.01% | 1772 |
|
|
2024
Q4 | $39.3K | Buy |
2,864
+2,556
| +830% | +$35K | ﹤0.01% | 1682 |
|
|
2024
Q3 | $8.44K | Buy |
+308
| New | +$8.44K | ﹤0.01% | 1602 |
|
|
2017
Q4 | – | Sell |
-7,249
| Closed | -$262K | – | 926 |
|
|
2017
Q3 | $262K | Sell |
7,249
-1,841,523
| -100% | -$66.6M | ﹤0.01% | 844 |
|
|
2017
Q2 | $47.8M | Sell |
1,848,772
-32,878
| -2% | -$850K | 0.46% | 81 |
|
|
2017
Q1 | $36.1M | Sell |
1,881,650
-3,473
| -0.2% | -$66.7K | 0.34% | 95 |
|
|
2016
Q4 | $31.4M | Sell |
1,885,123
-206,014
| -10% | -$3.43M | 0.28% | 101 |
|
|
2016
Q3 | $43M | Buy |
2,091,137
+567,379
| +37% | +$11.7M | 0.4% | 86 |
|
|
2016
Q2 | $46.6M | Buy |
1,523,758
+90,420
| +6% | +$2.77M | 0.43% | 84 |
|
|
2016
Q1 | $53.7M | Sell |
1,433,338
-108,977
| -7% | -$4.08M | 0.49% | 76 |
|
|
2015
Q4 | $66.6M | Sell |
1,542,315
-303,307
| -16% | -$13.1M | 0.59% | 58 |
|
|
2015
Q3 | $69.2M | Sell |
1,845,622
-110,644
| -6% | -$4.15M | 0.62% | 61 |
|
|
2015
Q2 | $66.5M | Buy |
1,956,266
+278,843
| +17% | +$9.48M | 0.6% | 69 |
|
|
2015
Q1 | $59.4M | Sell |
1,677,423
-115,198
| -6% | -$4.08M | 0.53% | 76 |
|
|
2014
Q4 | $61.1M | Buy |
1,792,621
+1,070,349
| +148% | +$36.5M | 0.53% | 74 |
|
|
2014
Q3 | $27.9M | Sell |
722,272
-1,086,238
| -60% | -$41.9M | 0.34% | 88 |
|
|
2014
Q2 | $70.4M | Sell |
1,808,510
-331,934
| -16% | -$12.9M | 0.61% | 71 |
|
|
2014
Q1 | $73.2M | Sell |
2,140,444
-482,288
| -18% | -$16.5M | 0.62% | 64 |
|
|
2013
Q4 | $55M | Buy |
2,622,732
+233,618
| +10% | +$4.9M | 0.5% | 84 |
|
|
2013
Q3 | $56.1M | Buy |
2,389,114
+276,755
| +13% | +$6.5M | 0.66% | 69 |
|
|
2013
Q2 | $56.8M | Buy |
+2,112,359
| New | +$56.8M | 0.7% | 65 |
|